MedTrace Logo

The DC Cohort Longitudinal HIV Status Neutral Study

NCT01206920 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 19000

Last updated 2026-02-02

No results posted yet for this study

Summary

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.

Conditions

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • George Washington University

    lead OTHER

Principal Investigators

  • Amanda D Castel, MD, MPH · George Washington University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2041-01-31
Completion
2041-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206920 on ClinicalTrials.gov